Jesika McKenzie
Psychiatric/Mental Health · Mesa, AZNPI 1427634997
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,192 of the $36,339 with a category attached, or 66.6%. Neurocrine Biosciences, Inc. accounts for 94.3% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $34,804, more than ten times the $541 reported in 2022. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $352.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$34K
- Acadia Pharmaceuticals Inc$928
- Teva Pharmaceuticals USA, Inc.$309
- Otsuka America Pharmaceutical, Inc.$292
- Alkermes, Inc.$217
- E.r. Squibb & Sons, L.L.C.$178
- plus $162 from 2 others
What the payments were for
- Consulting fees$6,18817%
- Speaking & faculty fees$24,19267%
- Travel & lodging$2,3957%
- Food & beverage$3,56410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 49 | $34,252 |
| Acadia Pharmaceuticals Inc | 27 | $928 |
| Teva Pharmaceuticals USA, Inc. | 6 | $309 |
| Otsuka America Pharmaceutical, Inc. | 12 | $292 |
| Alkermes, Inc. | 2 | $217 |
| E.r. Squibb & Sons, L.L.C. | 5 | $178 |
| Alpha Cognition USA, Inc. | 1 | $144 |
| Johnson & Johnson | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,339 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 50 | $2,039 |
| Hydroxyzine Hcl | 47 | $762 |
| Mirtazapine | 26 | $696 |
| Trazodone Hcl | 48 | $515 |
| Olanzapine | 17 | $392 |
| Sertraline Hcl | 30 | $390 |
| Risperidone | 21 | $359 |
| Escitalopram Oxalate | 17 | $311 |
| Clonazepam | 11 | $247 |
| Hydroxyzine Pamoate | 13 | $202 |
| Lorazepam | 20 | $195 |
| Duloxetine Hcl | 11 | $159 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Mesa
- Stacy UnderwoodMesa$252K
- Gail ZivMesa$29K
- Rebecca DepalmaMesa$19K
- Richard BealsMesa$10K
- Troy FultonMesa$9K
- Joan ButlerMesa$8K
- Julie AngileriMesa$6K
- Ana WilliamsMesa$6K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.